No Detail Found!

Therapeutic Potential of Carbonic Anhydrase Inhibitors.

Author(s)
Sumbal Bibi Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan
Tariq Javed Department of Pharmacy, LMDC, University of Health Sciences Lahore, Punjab, Pakistan
Fiaz Alam Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan
Atif Ali Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan
Ziaur Rehman Qureshi Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan
Sayyad Ali Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan
Majeed Ullah Department of Pharmacy, Kohat University of Science and Technology(KUST), Kohat, KPK, Pakistan
Muhammad Hassham Hassan Bin Asad Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan; Kazan (Volga Region) Federal University, Institute of Fundamental Medicine and Biology, Department of Genetics, Kremlevskaya Street, Kazan, Tatarstan, Russia; Laboratory INSERM UMR, Aix-Marseille University, Parc Scientifique et Technologique de Luminy, Avenue de Luminy, Bâtiment TPR2, Case 939, Marsikueille, France
Syed Muhammad Farid Hasan Department of Pharmaceutics, Faculty of Pharmacy, Karachi University, Karachi, Sind, Pakistan
Jean Marc Sabatier Laboratory INSERM UMR, Aix-Marseille University, Parc Scientifique et Technologique de Luminy, Avenue de Luminy, Bâtiment TPR2, Case 939, Marsikueille, France
AlbertA Rizvanov Kazan (Volga Region) Federal University, Institute of Fundamental Medicine and Biology, Department of Genetics, Kremlevskaya Street, Kazan, Tatarstan, Russia
Shafiq ur Rahman Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan
Abstract
Enzymes are biological catalyst involve in different biochemical reactions. But over activation of these biomolecules can cause disease thus different inhibitors and knockout therapies are use in current clinical practice. Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiological and pathological processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens. In addition to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel anti-obesity, anticancer and anti-infective drugs. Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease. This article discusses the biological rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clinical trials.
Publication Details
Page(s) 709-720
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 32, Issue: 2, Year: 2019

Request the full text from PASTIC

0

Citations

0

Downloads

101

Views